Related references
Note: Only part of the references are listed.[18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT
Xingyu Mu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Xiaoli Lou et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
Differentiated thyroid carcinoma: An update
Pepijn van Houten et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2023)
Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
Mamta Singh et al.
SEMINARS IN CANCER BIOLOGY (2023)
Clinical use of Molecular Data in Thyroid Nodules and Cancer
Ali S. Alzahrani
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)
Regulators of glucose uptake in thyroid cancer cell lines (vol 18, 83, 2020)
Shabnam Heydarzadeh et al.
CELL COMMUNICATION AND SIGNALING (2022)
Potential and Most Relevant Applications of Total Body PET/CT Imaging
Abass Alavi et al.
CLINICAL NUCLEAR MEDICINE (2022)
Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules
Elizabeth J. de Koster et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Molecular targets of tyrosine kinase inhibitors in thyroid cancer
Poupak Fallahi et al.
SEMINARS IN CANCER BIOLOGY (2022)
Fasting- Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
Claudio Vernieri et al.
CANCER DISCOVERY (2022)
Diagnostic Performance of Dynamic Contrast-Enhanced MRI and 18F-FDG PET/CT for Evaluation of Soft Tissue Tumors and Correlation with Pathology Parameters
Yu Zhang et al.
ACADEMIC RADIOLOGY (2022)
Joint interactions of carbon and nitrogen metabolism dominated by bicarbonate and nitrogen in Orychophragmus violaceus and Brassica napus under simulated karst habitats
Antong Xia et al.
BMC PLANT BIOLOGY (2022)
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Zubair W. Baloch et al.
ENDOCRINE PATHOLOGY (2022)
Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer
Bixiao Zhao et al.
SURGERY (2022)
Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial
Solomon A. Sowah et al.
GENOME MEDICINE (2022)
FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels
Chantal A. Lebbink et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Mediterranean Diet and Thyroid: An Interesting Alliance
Giuseppe Bellastella et al.
NUTRIENTS (2022)
Effect of Lactate Export Inhibition on Anaplastic Thyroid Cancer Growth and Metabolism
Bixiao Zhao et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2022)
Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology
S. J. Kierans et al.
JOURNAL OF PHYSIOLOGY-LONDON (2021)
Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p
Yanqi Li et al.
GENES & GENOMICS (2021)
Lactic acid in tumor invasion
Dun Niu et al.
CLINICA CHIMICA ACTA (2021)
Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)
Hui Fan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Federica Liotti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
Gladys Ferrere et al.
JCI INSIGHT (2021)
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
Varun Sasidharan Nair et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy
Jinwei Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Multikinase inhibitors in thyroid cancer: timing of targeted therapy
Matti L. Gild et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Metabolic regulation of the cancer-immunity cycle
Luis F. Somarribas Patterson et al.
TRENDS IN IMMUNOLOGY (2021)
Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer
Eun Jeong Ban et al.
ENDOCRINOLOGY AND METABOLISM (2021)
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics
Susi Zhu et al.
CANCER LETTERS (2021)
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up
Tim Brandenburg et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Management of VEGFR-Targeted TKI for Thyroid Cancer
Tomohiro Enokida et al.
CANCERS (2021)
HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA
Jia-Mei Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
PET/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer
Jasna Mihailovic et al.
SEMINARS IN NUCLEAR MEDICINE (2021)
LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
Xiukun Hou et al.
CELL DEATH & DISEASE (2021)
PET/CT in the management of differentiated thyroid cancer
Emilia Zampella et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2021)
Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis
Chang Liu et al.
BMC CANCER (2021)
STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis
Nan Huo et al.
CELL DEATH & DISEASE (2021)
Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS
Ji Min Oh et al.
THERANOSTICS (2021)
Lactate modulation of immune responses in inflammatory versus tumour microenvironments
Michelangelo Certo et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Cancer Plasticity: The Role of mRNA Translation
Laura J. Lee et al.
TRENDS IN CANCER (2021)
Autophagy and mitophagy in cancer metabolic remodelling
Fabio Ferro et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
The enhancement of glycolysis regulates pancreatic cancer metastasis
Jinshou Yang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies
Btissame El Hassouni et al.
SEMINARS IN CANCER BIOLOGY (2020)
Ketogenic diet combined with antioxidant N-acetylcysteine inhibits tumor growth in a mouse model of anaplastic thyroid cancer
Abha Aggarwal et al.
SURGERY (2020)
Crucial players in glycolysis: Cancer progress
Zaka Abbaszadeh et al.
GENE (2020)
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Shamir Cassim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Cheng Qin et al.
MOLECULAR CANCER (2020)
GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome
Salma Meziou et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Kulsoom Zahra et al.
FRONTIERS IN ONCOLOGY (2020)
Skeletal Muscle Metastasis in Papillary Thyroid Microcarcinoma Evaluated by F18-FDG PET/CT
Liviu Hitu et al.
DIAGNOSTICS (2020)
Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway
Caihong Wang et al.
CELL REPORTS (2020)
New Therapies for Advanced Thyroid Cancer
Diprajan Laha et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Comparison of simultaneous18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer
Michele Klain et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Regulators of glucose uptake in thyroid cancer cell lines
Shabnam Heydarzadeh et al.
CELL COMMUNICATION AND SIGNALING (2020)
pH gradient reversal fuels cancer progression
Tianyu Zheng et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
Molecular Markers Guiding Thyroid Cancer Management
Carolina Nylen et al.
CANCERS (2020)
Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis
Dae-Hwan Kim et al.
CLINICAL IMAGING (2020)
Phosphoribosyl Pyrophosphate Amidotransferase Promotes the Progression of Thyroid Cancer via Regulating Pyruvate Kinase M2
Bing Liu et al.
ONCOTARGETS AND THERAPY (2020)
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2
Chunqing Wang et al.
NATURE COMMUNICATIONS (2020)
Kidney Cancer, Version 1.2021 Featured Updates to the NCCN Guidelines
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu et al.
CELL DEATH & DISEASE (2020)
The Warburg Effect 97 Years after Its Discovery
Rosa Maria Pascale et al.
CANCERS (2020)
Clinical Development of BRAF plus MEK Inhibitor Combinations
Vivek Subbiah et al.
TRENDS IN CANCER (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential
Frank Madeo et al.
CELL METABOLISM (2019)
Mitochondrial metabolism is inhibited by the HIF1-MYC-PGC-1 axis in BRAF V600E thyroid cancer
Yanyan Gao et al.
FEBS JOURNAL (2019)
The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis
Bo Zhang et al.
GENE (2019)
S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2
Lili Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L. Bryant et al.
NATURE MEDICINE (2019)
Oncometabolites as biomarkers in thyroid cancer: a systematic review
Fatemeh Khatami et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression
Sajid Amin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Sunitinib in the Treatment of Thyroid Cancer
Silvia Martina Ferrari et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Proteomic characterization of early lung response to breast cancer metastasis in mice
Anna Kurpinska et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
Giuseppe Sammarco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Reprogramming of Energy Metabolism: Increased Expression and Roles of Pyruvate Carboxylase in Papillary Thyroid Cancer
Aurelie Strickaert et al.
THYROID (2019)
Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
Deepshikha Mishra et al.
CANCERS (2019)
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial
Sarah R. Brown et al.
BMC CANCER (2019)
Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer
Miguel A. Zaballos et al.
ENDOCRINE-RELATED CANCER (2019)
The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela
Rosa Angela Cardone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Warburg effect and its role in tumourigenesis
Maphuti T. Lebelo et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Maria E. Cabanillas et al.
ENDOCRINE REVIEWS (2019)
Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer
Xuguang Zhu et al.
ENDOCRINE-RELATED CANCER (2019)
18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?
M. Wartski et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2019)
Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
Mohamed Aashiq et al.
CANCERS (2019)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Filetti et al.
ANNALS OF ONCOLOGY (2019)
The Acidic Tumor Microenvironment as a Driver of Cancer
Ebbe Boedtkjer et al.
Annual Review of Physiology (2019)
LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma
Xiao-ming Hou et al.
BIOSCIENCE REPORTS (2019)
Tumor pH and metastasis: a malignant process beyond hypoxia
Oliver Thews et al.
CANCER AND METASTASIS REVIEWS (2019)
Dysregulation of glutaminase and glutamine synthetase in cancer
Jose M. Mates et al.
CANCER LETTERS (2019)
HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
Ayako Nagao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium
Markus Luster et al.
THYROID (2019)
LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition
Hongshi Cai et al.
FRONTIERS IN ONCOLOGY (2019)
Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction
Farzaneh Jafary et al.
SCIENTIFIC REPORTS (2019)
AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis
Bin Zheng et al.
CELLULAR SIGNALLING (2018)
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Glenn J. Hanna et al.
CLINICAL CANCER RESEARCH (2018)
Iodine/FDG Flip-Flop Phenomenon Inside a Large Metastatic Thyroid Cancer Lesion Better Characterized on SPECT/CT and PET/CT Studies
Paulo Schiavom Duarte et al.
CLINICAL NUCLEAR MEDICINE (2018)
Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy
Yunli Shi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard et al.
DRUG RESISTANCE UPDATES (2018)
PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord
Binbin Wang et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
Ming-Chuan Hsu et al.
MOLECULAR CANCER (2018)
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied
Silvia M. Ferrari et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress
Pedro Gonzalez-Menendez et al.
REDOX BIOLOGY (2018)
Metabolic Reprogramming in Thyroid Carcinoma
Raquel Guimaraes Coelho et al.
FRONTIERS IN ONCOLOGY (2018)
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival
Gaurav Pathria et al.
EMBO JOURNAL (2018)
ASSOCIATION BETWEEN OXIDATIVE STRESS AND MELANOMA PROGRESSION
Jelena Pantic Bisevac et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2018)
Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
Alessandro Stecco et al.
DIAGNOSTICS (2018)
Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway
Xueyan Zhang et al.
MOLECULAR MEDICINE REPORTS (2017)
Metabolic Interactions in the Tumor Microenvironment
Costas A. Lyssiotis et al.
TRENDS IN CELL BIOLOGY (2017)
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
Lingxiao Cheng et al.
ONCOTARGET (2017)
Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis
Ji Wang et al.
ONCOTARGET (2017)
Group V Secreted Phosphapase A2 Induces the Release of Proanglogenic and Antianglogenic Factors by Human Neutrophils
Stefania Loffredo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Potential role of Metabolic intervention in the Management of Advanced Differentiated thyroid cancer
Sri Harsha Tella et al.
FRONTIERS IN ONCOLOGY (2017)
LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES
Dania Hirsch et al.
ENDOCRINE PRACTICE (2017)
Suppression of FIP200 and autophagy by tumor-derived lactate promotes naive T cell apoptosis and affects tumor immunity
Houjun Xia et al.
SCIENCE IMMUNOLOGY (2017)
The Glycogen Shunt Maintains Glycolytic Homeostasis and the Warburg Effect in Cancer
Robert G. Shulman et al.
TRENDS IN CANCER (2017)
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Rigel J. Kishton et al.
CELL METABOLISM (2017)
Targeted Therapy in Thyroid Cancer: State of the Art
L. Valerio et al.
CLINICAL ONCOLOGY (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
J. Chen et al.
ANNALS OF ONCOLOGY (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
PKM2, cancer metabolism, and the road ahead
Talya L. Dayton et al.
EMBO REPORTS (2016)
The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice
A. Kukulska et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma
Melanie Ruf et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells
Kento Kurata et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
James Nagarajah et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The HK2 Dependent Warburg Effect and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
Pawel Lis et al.
MOLECULES (2016)
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
Aaron Boudreau et al.
NATURE CHEMICAL BIOLOGY (2016)
Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Min Peng et al.
SCIENCE (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
Asaf Spiegel et al.
CANCER DISCOVERY (2016)
Serine and one-carbon metabolism in cancer
Ming Yang et al.
NATURE REVIEWS CANCER (2016)
Negative feedback of glycolysis and oxidative phosphorylation: Mechanisms of and reasons for it
S. S. Sokolov et al.
BIOCHEMISTRY-MOSCOW (2015)
Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
Paul Kachel et al.
BMC CANCER (2015)
Metabolic reprogramming supports the invasive phenotype in malignant melanoma
Ingrid J. Bettum et al.
CANCER LETTERS (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
FDA Approval Summary: Lenvatinib for Progressive, Radio-iodine-Refractory Differentiated Thyroid Cancer
Abhilasha Nair et al.
CLINICAL CANCER RESEARCH (2015)
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
Francis Worden et al.
ENDOCRINE-RELATED CANCER (2015)
Metabolic Reprogramming of Immune Cells in Cancer Progression
Subhra K. Biswas
IMMUNITY (2015)
Angiogenesis and lymphangiogenesis in inflammatory skin disorders
Gilda Varricchi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Lymph node and distant metastases of thyroid gland cancer. Metastases in the thyroid glands
K. W. Schmid
PATHOLOGE (2015)
Cabozantinib in Thyroid Cancer
Poupak Fallahi et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2015)
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression
Xin Ye et al.
TRENDS IN CELL BIOLOGY (2015)
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
Weibo Luo et al.
Oncotarget (2015)
VEGF expression, microvessel density and dendritic cell decrease in thyroid cancer
Maya Gulubova et al.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating Oxidative Phosphorylation
Rizwan Haq et al.
CLINICAL CANCER RESEARCH (2014)
Pharmacological suppression of the Ras/MAPK pathway in thyroid carcinoma cells can provoke opposite effects on cell migration and proliferation: The appearance of yin-yang effects and the need of combinatorial treatments
Alexander Glassmann et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Mechanisms of lymphatic metastasis
Sinem Karaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma
Zorica Milosevic et al.
TRANSLATIONAL RESEARCH (2014)
Acidic extracellular microenvironment and cancer
Yasumasa Kato et al.
CANCER CELL INTERNATIONAL (2013)
Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer
Hanbyoul Cho et al.
CANCER INVESTIGATION (2013)
Effects of limiting energy availability via diet and physical activity on mammalian target of rapamycin-related signaling in rat mammary carcinomas
Weiqin Jiang et al.
CARCINOGENESIS (2013)
Vandetanib for the Treatment of Medullary Thyroid Cancer
Nicole G. Chau et al.
CLINICAL CANCER RESEARCH (2013)
Aberrant Overexpression of Pyruvate Kinase M2 Is Associated With Aggressive Tumor Features and the BRAF Mutation in Papillary Thyroid Cancer
Chen Feng et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Clinical Outcomes and Molecular Profile of Differentiated Thyroid Cancers With Radioiodine-Avid Distant Metastases
M. M. Sabra et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Relief of Feedback Inhibition of HER3 Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in BRAF-Mutant Thyroid Carcinomas
Cristina Montero-Conde et al.
CANCER DISCOVERY (2013)
cGMP-Selective Phosphodiesterase Inhibitors Stimulate Mitochondrial Biogenesis and Promote Recovery from Acute Kidney Injury
Ryan M. Whitaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Cellular and molecular basis for thyroid cancer imaging in nuclear medicine
Massimo Bongiovanni et al.
CLINICAL AND TRANSLATIONAL IMAGING (2013)
Exercise tames the wild side of the Myc network: a hypothesis
Kishorchandra Gohil et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma
Florian Grabellus et al.
CLINICAL NUCLEAR MEDICINE (2012)
Glucose transporters in cancer metabolism
Kehinde Adekola et al.
CURRENT OPINION IN ONCOLOGY (2012)
Glycolytic Inhibition Alters Anaplastic Thyroid Carcinoma Tumor Metabolism and Improves Response to Conventional Chemotherapy and Radiation
Vlad C. Sandulache et al.
MOLECULAR CANCER THERAPEUTICS (2012)
A two-way street: reciprocal regulation of metabolism and signalling
Kathryn E. Wellen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
Eric T. Clambey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation
Jiangbin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Role of Rac1-dependent NADPH oxidase in the growth of pancreatic cancer
J. Du et al.
CANCER GENE THERAPY (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The mTOR protein as a target in thyroid cancer
Elaine Cristina Lima de Souza et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Initial steps of metastasis: Cell invasion and endothelial transmigration
Franziska van Zijl et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)
Thyroid cancer stem cells
Reigh-Yi Lin
NATURE REVIEWS ENDOCRINOLOGY (2011)
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
Qian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
R. C. Smallridge et al.
CLINICAL ONCOLOGY (2010)
BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus
Dingxie Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors
Motoyasu Saji et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Increased Expression of Vascular Endothelial Growth Factor and Its Receptors, VEGFR-1 and VEGFR-2, in Medullary Thyroid Carcinoma
Clarissa Capp et al.
THYROID (2010)
Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of Rapamycin
Dingxie Liu et al.
CANCER RESEARCH (2009)
Control of autophagy by oncogenes and tumor suppressor genes
M. C. Maiuri et al.
CELL DEATH AND DIFFERENTIATION (2009)
Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
Ning Jin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
Martin J. Schlumberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Role and regulation of prolyl hydroxylase domain proteins
G-H Fong et al.
CELL DEATH AND DIFFERENTIATION (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers
Zhi Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Potent inhibition of thyroid cancer cells by the MEK inhibitor PD0325901 and its Potentiation by suppression of the PI3K and NF-κB pathways
Dingxie Liu et al.
THYROID (2008)
Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer
Fumihiko Furuya et al.
CARCINOGENESIS (2007)
Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma
Hwei-Ming Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Mutant V600E BRAF increases hypoxia inducible factor-1α expression in melanoma
Suresh M. Kumar et al.
CANCER RESEARCH (2007)
Energy metabolism in tumor cells
Rafael Moreno-Sanchez et al.
FEBS JOURNAL (2007)
An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases
Dong Wook Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Lactate stimulates endothelial cell migration
Stefan Beckert et al.
WOUND REPAIR AND REGENERATION (2006)
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
E Gottfried et al.
BLOOD (2006)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Advances in Na+/I- symporter (NIS) research in the thyroid and beyond
O Dohán et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
MCT1 and its accessory protein CD147 are differentially regulated by TSH in rat thyroid cells
A Fanelli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral spuamous cell carcinoma
M Kunkel et al.
CANCER (2003)
Physical activity and cancer prevention: Etiologic evidence and biological mechanisms
CM Friedenreich et al.
JOURNAL OF NUTRITION (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Cooperation and competition in the evolution of ATP-producing pathways
T Pfeiffer et al.
SCIENCE (2001)
Accelerated publication -: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
RC Osthus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)